Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
iShares Health Innovation Active ETF (BMED) belongs to the Healthcare Technology segment. iShares Global Healthcare ETF (IXJ) is part of the Global Large Cap segment. Both ETFs have the same top 3 sector exposures: Health Care and Consumer Discretionary. BMED is more expensive with a Total Expense Ratio (TER) of 0.77%, versus 0.4% for IXJ. BMED is down -5.49% year-to-date (YTD) with +$4M in YTD flows. IXJ performs better with -3.07% YTD performance, and -$688M in YTD flows. Run a side-by-side ETF comparison of BMED and IXJ below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | BMED IXJ | -6.03%-6.62% | -5.68%-3.29% | -5.49%-3.07% | +16.79%+5.92% | +27.36%+23.67% | -1.83%+32.59% |
| Flows | BMED IXJ | +$1M-$599M | +$4M-$664M | +$4M-$688M | +$7M-$427M | +$4M-$883M | +$5M+$219M |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | BMED IXJ | +15.26%+13.13% | +17.92%+16.82% | +15.51%+13.09% | +17.58%+13.81% |
| Max drawdown | BMED IXJ | -10.40%-7.40% | -14.01%-10.89% | -19.76%-18.04% | -33.96%-18.04% |
| Max drawdown duration | BMED IXJ | 50d12d | 113d196d | 237d490d | 1586d490d |
BMED | IXJ | |
Last sale 3/13/2026 at 1:30 PM | $28.63 | $94.30 |
| Previous close 03/12/2026 | $28.78 | $94.78 |
| Consolidated volume 03/12/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
BMED | IXJ | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
BMED | IXJ | |
|---|---|---|
| Last price | $28.63 | $94.30 |
| 1D performance | -0.52% | -0.51% |
| AuM | $10.31 M | $3.71 B |
| E/R | 0.77% | 0.4% |
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Join J.P. Morgan’s Bram Kaplan, Head of Americas Equity Derivatives Strategy and Matt Kaufman from Calamos Investments as they dive into the growing global opportunity in autocallable income—an increasingly dominant strategy within structured products, now available through ETFs.
Accepted for 1 CE Credit
